This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garbutt, J.
Right arrow Articles by Shackelford, P. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garbutt, J.
Right arrow Articles by Shackelford, P. G.
Related Collections
Right arrow Infectious Disease & Immunity
PEDIATRICS Vol. 114 No. 2 August 2004, pp. 342-347

Developing Community-Specific Recommendations for First-Line Treatment of Acute Otitis Media: Is High-Dose Amoxicillin Necessary?

Jane Garbutt, MBChB*,{ddagger}, Joseph W. St. Geme, III, MD{ddagger}, Ariane May, MD, MPH{ddagger}, Gregory A. Storch, MD{ddagger} and Penelope G. Shackelford, MD{ddagger}

* Division of General Medical Sciences
{ddagger} Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri

Objectives. National recommendations are to use high-dose amoxicillin (80–90 mg/kg per day) to treat uncomplicated acute otitis media (AOM) in children who are at high risk for infection with nonsusceptible Streptococcus pneumoniae (NSSP). However, high-dose treatment may not be necessary if the local prevalence of NSSP is low. The objective of this study was to estimate the local prevalence of NSSP in children with acute upper respiratory illnesses and to develop community-specific recommendations for first-line empiric treatment of AOM.

Methods. We conducted a cross-sectional prevalence study in the offices of 7 community pediatricians in St Louis, Missouri. S pneumoniae was isolated from nasopharyngeal swabs collected from children who were younger than 7 years and had AOM, nonspecific upper respiratory infection, cough, acute sinusitis, or pharyngitis. Children were excluded from the study when they had received an antibiotic in the previous 4-week period. Parents and providers completed a brief questionnaire to assess risk factors for carriage of NSSP. On the basis of National Clinical Chemistry Laboratory Standards, isolates with a penicillin minimum inhibitory concentration ≥0.12 µg/mL were considered to be nonsusceptible to penicillin (NSSP), and isolates with a penicillin minimum inhibitory concentration >2 µg/mL were categorized as nonsusceptible to standard-dose amoxicillin (35–45 mg/kg per day; NSSP-A).

Results. S pneumoniae was isolated from the nasopharynx of 85 (40%) of 212 study patients (95% confidence interval [CI]: 33%–47%); 41 (48%) of 85 isolates were NSSP (95% CI: 37%–59%), and 6 (7%) were NSSP-A (95% CI: 1.5%–13%). Among the 212 study patients, the prevalence of NSSP was 19% (95% CI: 14%–25%), and the prevalence of NSSP-A was 3% (95% CI: 0.6%–5%). Carriage of NSSP was increased in child care attendees compared with nonattendees (29% vs 14%; odds ratio: 2.6; 95% CI: 1.3–5.2).

Conclusions. In our community, although the prevalence of NSSP among isolates of S pneumoniae identified from the nasopharynx of symptomatic children is high (48%), the probability of NSSP-A infection among symptomatic children is <5%. Our data support a recommendation to treat most children who have uncomplicated AOM with standard-dose amoxicillin. Children who attend child care or have recently received an antibiotic may require treatment with high-dose amoxicillin. Other communities may benefit from a similar assessment of the prevalence of NSSP and NSSP-A.

Key Words: Streptococcus pneumoniae • acute otitis media • treatment guidelines

Abbreviations: AOM, acute otitis media • NSSP, (penicillin) nonsusceptible Streptococcus pneumoniae • ABC, Active Bacterial Core • MIC, minimum inhibitory concentration • URI, (nonspecific) upper respiratory infection • NSSP-A, nonsusceptible Streptococcus pneumoniae to standard-dose amoxicillin • CI, confidence interval • OR, odds ratio

Received for publication Aug 28, 2003; Accepted Dec 26, 2003.




This article has been cited by other articles:


Home page
 Arch. Dis. Child.Home page
S L Block
Searching for the Holy Grail of acute otitis media.
Arch. Dis. Child., December 1, 2006; 91(12): 959 - 961.
[Full Text] [PDF]

Home page
 PediatricsHome page
J. Garbutt, I. Rosenbloom, J. Wu, and G. A. Storch
Empiric first-line antibiotic treatment of acute otitis in the era of the heptavalent pneumococcal conjugate vaccine.
Pediatrics, June 1, 2006; 117(6): e1087 - e1094.
[Abstract] [Full Text] [PDF]